Zynerba Pharmaceuticals Inc. (ZYNE) dipped -5.34% or -0.63 to $11.16. It is approximately 1.15 million shares traded, which is 40.61% compare to the average total volume 2.83 million. The market cap of ZYNE is $235.20 million. The year to date change is 211.59%. The 52 week price range is from $2.75 to $16.47. Price of ZYNE have changed -8.82% during last week. It have changed 2.97% over last month, 132.54% over last 3 months, 129.82% over last 6 months and 7.87% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 10.49. It is -6.00% below current price. The 200-day Moving Averages for ZYNE is 6.84. It is -38.71% below current price. The 52-week High is 16.47. It is 47.58% from the current price. The 52-week Low is 2.75. It is -75.36% from current price.
There are some statistics of ZYNE. It is has market cap $235.20 million. The share outstanding is 21.07 million. The average volume is 2.83 million. The percent of top 15 Institution holding is 31.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -62.10%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -54.28%.